SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Being sugar-coated doesn’t just help the medicine go down, as the song goes, but it can also help a virus evade the immune ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' ...

In December 2024, a rumor began spreading online that a team of researchers at Yale University had found the "spike protein" of the SARS-CoV-2 virus, which is responsible for the COVID-19 illness ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Scientists at Scripps Research have developed a universal vaccine, offering protection against multiple coronaviruses, ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

Then, the antibody called CoV2-biRN7 can attach to the spike protein's receptor-binding domain, or RBD, thus preventing the protein from infecting healthy human cells. In an in-vitro test (i.e. in ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.

He adds that the high rate of mutation seen in the SARS-CoV-2 virus -- specifically, the receptor binding domain on the virus' spike protein -- has led to an unprecedented number of COVID-19 ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...